139 related articles for article (PubMed ID: 37487808)
1. A PET-CT score for discriminating malignant from benign pleural effusions.
Simó M; Persiva O; Sánchez L; Montoro B; Vázquez A; Sansano I; Alemán C
Med Clin (Barc); 2023 Nov; 161(10):422-428. PubMed ID: 37487808
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
[TBL] [Abstract][Full Text] [Related]
3. Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions.
Porcel JM; Pardina M; Bielsa S; González A; Light RW
Chest; 2015 Feb; 147(2):513-519. PubMed ID: 25255186
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis.
Fjaellegaard K; Koefod Petersen J; Reuter S; Malene Fischer B; Gerke O; Porcel JM; Frost Clementsen P; Laursen CB; Bhatnagar R; Bodtger U
Lung Cancer; 2021 Dec; 162():106-118. PubMed ID: 34775214
[TBL] [Abstract][Full Text] [Related]
5. [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
Liao R; Yang X; Wang S; Zhou Q; Nie Q; Zhong W; Dong S; Wu Y
Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):652-5. PubMed ID: 23164351
[TBL] [Abstract][Full Text] [Related]
6. The contribution of PET/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma.
Budak A; Yanarateş A; Budak E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):353-358. PubMed ID: 37172933
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
Porcel JM; Hernández P; Martínez-Alonso M; Bielsa S; Salud A
Chest; 2015 Feb; 147(2):502-512. PubMed ID: 25188411
[TBL] [Abstract][Full Text] [Related]
8. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
Gupta NC; Rogers JS; Graeber GM; Gregory JL; Waheed U; Mullet D; Atkins M
Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
[TBL] [Abstract][Full Text] [Related]
9. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
Sun Y; Yu H; Ma J; Lu P
PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933
[TBL] [Abstract][Full Text] [Related]
10. FDG PET of pleural effusions in patients with non-small cell lung cancer.
Erasmus JJ; McAdams HP; Rossi SE; Goodman PC; Coleman RE; Patz EF
AJR Am J Roentgenol; 2000 Jul; 175(1):245-9. PubMed ID: 10882281
[TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation.
Letovanec I; Allenbach G; Mihaescu A; Nicod Lalonde M; Schmidt S; Stupp R; Fitting JW; Boubaker A; Ris HB; Prior JO
Nuklearmedizin; 2012; 51(5):186-93. PubMed ID: 22584348
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
13. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
14. Derivation and validation of a 18F-FDG PET/CT scoring model to predict malignant pleural effusion.
Lu P; Sun Y; Liang B; Yu L
Nucl Med Commun; 2022 Feb; 43(2):177-185. PubMed ID: 34864810
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CT findings for diagnosis of pleural effusions.
Arenas-Jiménez J; Alonso-Charterina S; Sánchez-Payá J; Fernández-Latorre F; Gil-Sánchez S; Lloret-Llorens M
Eur Radiol; 2000; 10(4):681-90. PubMed ID: 10795555
[TBL] [Abstract][Full Text] [Related]
16. Can PET/CT be used more effectively in pleural effusion evaluation?
Simsek FS; Yuksel D; Yaylali O; Aslan HS; Kılıçarslan E; Bir F; Arslan M; Can FE; Ugurlu E
Jpn J Radiol; 2021 Dec; 39(12):1186-1194. PubMed ID: 34165683
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
Duysinx B; Nguyen D; Louis R; Cataldo D; Belhocine T; Bartsch P; Bury T
Chest; 2004 Feb; 125(2):489-93. PubMed ID: 14769729
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography.
Toaff JS; Metser U; Gottfried M; Gur O; Deeb ME; Lievshitz G; Mercer D; Even-Sapir E
Invest Radiol; 2005 Apr; 40(4):204-9. PubMed ID: 15770138
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.
Nakajima R; Abe K; Sakai S
Medicine (Baltimore); 2015 Jul; 94(29):e1010. PubMed ID: 26200610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
